Cash ManagementYear-to-date operating cash flow improved to +$3.8 million compared to -$4.1 million last year, indicating better cash management.
Financial PerformanceThe company reported Adjusted EBITDA of $13.6M, which was ahead of market expectations of $12.2M.
Occupancy RatesEnhanced clinical response processes and a 4% YoY increase in move-ins contributed to spot occupancy that improved to 88.2%.